Welcome to our dedicated page for Meiwu Technology Co SEC filings (Ticker: WNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Meiwu Technology Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Meiwu Technology Co's regulatory disclosures and financial reporting.
Meiwu Technology Company Limited reported significant leadership changes and a new executive employment agreement. Three directors, including director and chief operation officer Ms. Qiufei Chen, resigned in late January 2026 for personal reasons, and the company stated there were no disagreements related to operations, policies, or practices.
The Board appointed Handy Wijaya as Co‑Chief Executive Officer effective January 29, 2026, under a one‑year employment agreement with an annual base salary of $150,000 and severance protections for termination without cause or in a change‑of‑control transaction. The Board also appointed Yan Siook Yi as a director and chairman of the audit committee, and reassigned existing director Hanwu Yang to key board committee roles to fill vacancies.
Meiwu Technology Company Limited completed a best-efforts primary offering of 38,000,000 ordinary shares at $0.80 per share under an effective Form F-1 registration. The company reports net proceeds of $30,224,051, which it currently plans to use to further develop its functional skincare business and to purchase bitcoins as part of its treasury asset allocation, consistent with the registration statement.
The filing also notes that 12,000,000 previously issued ordinary shares sold to chairman Changbin Xia at $0.80 per share are registered for resale, with no proceeds going to the company. Mr. Xia agreed to a 180-day lock-up restricting sales and similar dispositions of his ordinary shares and related securities.
Meiwu Technology Company Limited is conducting a mixed securities offering consisting of a best-efforts primary sale of up to 38,000,000 Ordinary Shares at a fixed price of $0.8 per share and a separate resale of 12,000,000 Ordinary Shares by its chairman, Changbin Xia.
The company will receive proceeds only from the primary offering and plans to allocate approximately 9.5% to online marketing for its “Gongfuzhiye (功肤之夜)” brand, 28% to build a network of over 1,500 offline affiliate stores, 12.5% for working capital and corporate purposes, and about 50% for bitcoin investments as part of a bitcoin treasury strategy. Shares outstanding are expected to increase from 15,643,353 Ordinary Shares before the offering to 53,643,353 after the primary issuance. Meiwu’s Ordinary Shares trade on Nasdaq under the symbol “WNW,” and the last reported price on Nasdaq was $1.52 per share on January 22, 2026.
The company is a British Virgin Islands holding company whose operations are conducted through subsidiaries in China, and it describes extensive risks tied to PRC regulation, potential government intervention, foreign exchange and dividend restrictions, and possible future impacts of the HFCAA and evolving cybersecurity and overseas listing rules. The chairman’s resale shares are subject to a 180-day lock-up from January 26, 2026, and the company states it does not expect to pay dividends for the foreseeable future.
Meiwu Technology Company Limited is registering up to $200,000,000 of ordinary shares, preferred shares, debt securities, warrants, rights and units that it may sell from time to time under a shelf program. The company is a British Virgin Islands holding entity whose operations are conducted through subsidiaries in China, so buyers receive an interest in the offshore parent, not in the PRC operating companies.
The filing highlights substantial legal and operational risks tied to PRC regulation, potential intervention in overseas listings, data and cybersecurity oversight, capital controls, and dividend restrictions. It also discusses HFCAA-related delisting risk, though the current auditor is subject to PCAOB inspection, and notes that no VIE structure is in place following a 2024 restructuring.
Meiwu describes a strategic pivot toward functional skincare, which now represents most revenue, and outlines a planned bitcoin treasury strategy funded from a separate F‑1 equity offering, with an intention to allocate a portion of corporate treasury into bitcoin held with a U.S. custodian.
Meiwu Technology Company Limited files an amended F-1 for a mixed offering registering 38,000,000 new ordinary shares and 12,000,000 shares for resale. The primary shares are offered on a best-efforts basis at a fixed price of $0.8 per share, with no minimum raise, while the company receives no proceeds from the selling shareholder’s 12,000,000 shares. Net primary proceeds are earmarked approximately 9.5% for online marketing of the “Gongfuzhiye (功肤之夜)” skincare brand, 28% to build over 1,500 offline affiliate stores, 12.5% for working capital, and 50% for bitcoin investments. Meiwu is a British Virgin Islands holding company whose operations are in China, so cash upstreaming depends on PRC rules and FX controls, and it highlights legal, regulatory, HFCAA and PRC policy risks, including the possibility of stricter oversight of China-based issuers. This amendment mainly adds unaudited financials for the six months ended June 30, 2025 and 2024 and updates certain exhibits.
Meiwu Technology Company Limited is filing a Form F-1 to register a mixed offering of up to 38,000,000 ordinary shares in a primary best-efforts offering at $0.8 per share and 12,000,000 ordinary shares for resale by its chairman, Changbin Xia. Meiwu will receive proceeds only from the primary sale and plans to allocate about 9.5% to online marketing for its “Gongfuzhiye (功肤之夜)” skincare brand, 28% to build over 1,500 offline affiliate stores, 12.5% for working capital, and approximately 50% for bitcoin investments. The company is a British Virgin Islands holding company whose operations are conducted through subsidiaries in China, and it highlights significant PRC regulatory, cash-transfer, dividend, HFCAA, and China-related policy risks, including the possibility that Chinese government actions could materially affect its operations and the value of its Nasdaq-listed shares.
Meiwu Technology Company Limited filed a Form 6-K as a foreign private issuer, mainly to share updated interim information with investors. The filing furnishes unaudited condensed consolidated financial statements and related notes for the six months ended June 30, 2025 and 2024, along with a management discussion and analysis of its financial condition and operating results.
Meiwu Technology Company Limited filed a Form S-8 to register 475,220 ordinary shares, no par value, issuable under its 2025 Equity Incentive Plan. The registration statement incorporates the company's Form 20-F and certain Form 6-K reports by reference and lists the 2025 Plan, counsel opinions, and consents as exhibits.
The document confirms the company is organized in the British Virgin Islands, identifies its principal office in Xiamen, China, and indicates the company is a non-accelerated filer and an emerging growth company. Plan documents required for recipients are to be provided separately and are not filed as part of Part I of the S-8.